Cargando…
Characterization of lung adenocarcinoma based on immunophenotyping and constructing an immune scoring model to predict prognosis
Background: Lung cancer poses great threat to human health, and lung adenocarcinoma (LUAD) is the main subtype. Immunotherapy has become first line therapy for LUAD. However, the pathogenic mechanism of LUAD is still unclear. Methods: We scored immune-related pathways in LUAD patients using single s...
Autores principales: | Liu, Mengfeng, Xiao, Qifan, Yu, Xiran, Zhao, Yujie, Qu, Changfa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806149/ https://www.ncbi.nlm.nih.gov/pubmed/36601052 http://dx.doi.org/10.3389/fphar.2022.1081244 |
Ejemplares similares
-
Establishing a Novel Gene Signature Related to Histone Modifications for Predicting Prognosis in Lung Adenocarcinoma
por: Liu, Mengfeng, et al.
Publicado: (2022) -
Comparative analyses of salivary exosomal miRNAs for patients with or without lung cancer
por: Liu, Mengfeng, et al.
Publicado: (2023) -
Predictive Value of Gene Databases in Discovering New Biomarkers and New Therapeutic Targets in Lung Cancer
por: Liu, Mengfeng, et al.
Publicado: (2023) -
A Novel Immune-Prognosis Index Predicts the Benefit of Lung Adenocarcinoma Patients
por: Bai, Yuquan, et al.
Publicado: (2022) -
A novel platelet risk score for stratifing the tumor immunophenotypes, treatment responses and prognosis in bladder carcinoma: results from real-world cohorts
por: Deng, Dingshan, et al.
Publicado: (2023)